pep-04997 v1 CC-BY-SA-4.0
BAP1 appetite & blood-sugar peptide
A lab-stage peptide aimed at the same body system targeted by weight-loss and diabetes drugs like Ozempic; not approved for use.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.729
pTM0.739
avg pLDDT40.5
ranking score0.841
STRUCTURE · PEP-04997 × GLP-1R
ranking0.841
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
15101520253035404550
MDGEGHDINI WGARMSPSPA AAPVSATRGA PWSGCEGCPS RAADRRCVCH
in the news
details
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.7286885976791382 | openfold3-mlx |
| ranking score | 0.8408144116401672 | openfold3-mlx |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 0.781 | global PDE — lower = better |
| disorder | 0.220 | fraction disordered |
| chain pair ipTM (A, B) | 0.729 | interface quality |
▸3-letter notation
Met-Asp-Gly-Glu-Gly-His-Asp-Ile-Asn-Ile-Trp-Gly-Ala-Arg-Met-Ser-Pro-Ser-Pro-Ala-Ala-Ala-Pro-Val-Ser-Ala-Thr-Arg-Gly-Ala-Pro-Trp-Ser-Gly-Cys-Glu-Gly-Cys-Pro-Ser-Arg-Ala-Ala-Asp-Arg-Arg-Cys-Val-Cys-His
▸recipeopenfold3-mlx 0.3.1
| parameter | value |
|---|---|
| model | openfold3-mlx 0.3.1 |
| weights | — |
| hardware | — |
| mlx version | — |
| python | — |
| random seed | — |
| msa strategy | — |
| diffusion samples | 1 |
| runtime | 526s |
| predicted by | mlx@peptide |
| predicted at | 2026-04-14 |
▸citationbibtex
peptidemodel (2026). BAP1 appetite & blood-sugar peptide (pep-04997, v1). PeptideModel. https://peptidemodel.com/card/pep-04997
@peptide{pep04997,
sequence = {MDGEGHDINIWGARMSPSPAAAPVSATRGAPWSGCEGCPSRAADRRCVCH},
target = {glp-1r},
author = {peptidemodel},
year = {2026},
status = {computed}
} related peptides
references
discussion
sign in to comment